Lipid peroxidation is a fundamental pathological process in neurodegenerative diseases, representing a chain reaction of oxidative damage to polyunsaturated fatty acids (PUFAs) in cell membranes. This generates reactive lipid species that directly contribute to neuronal dysfunction and death[1]. The brain is particularly vulnerable to peroxidative damage due to its high lipid content (approximately 50% of dry weight), high oxygen consumption, and relatively limited antioxidant capacity compared to other organs[2].
In neurodegenerative diseases, elevated lipid peroxidation contributes to membrane damage and dysfunction, neuroinflammation, protein oxidation, and cellular energy failure. The process generates diverse reactive species including lipid hydroperoxides and electrophilic aldehydes such as 4-hydroxynonenal (4-HNE), malondialdehyde (MDA), and acrolein, which propagate damage through covalent modifications of proteins and DNA[3]. Understanding lipid peroxidation biology provides opportunities for developing targeted therapeutic interventions.
Lipid peroxidation occurs via a three-step chain reaction[4]:
Initiation:
Propagation:
Termination:
Hydroxyl Radical (•OH):
Peroxyl Radicals (ROO•):
Aldehyde Products:
Peroxidation profoundly alters membrane properties[5]:
Lipid peroxidation is extensively involved in AD pathogenesis[6]:
Amyloid Interaction:
Tau Pathology:
Clinical Correlations:
Dopaminergic neurons show particular vulnerability to lipid peroxidation[7]:
Neuromelanin Interactions:
Mitochondrial Connections:
Therapeutic Targets:
Motor neuron disease involves significant lipid peroxidation[8]:
Oxidative Stress Markers:
Therapeutic Implications:
Polyglutamine pathology involves lipid peroxidation[9]:
Demyelinating disease shows lipid peroxidation involvement[10]:
Glutathione Peroxidase (GPx):
Selenium-dependent enzyme family that reduces lipid hydroperoxides[11]:
Peroxiredoxins (Prxs):
Thiol-specific peroxidases reducing peroxides including lipid peroxides[12]:
Catalase:
Hydrogen peroxide decomposition:
Vitamin E (α-Tocopherol):
Primary lipid-soluble antioxidant[13]:
Coenzyme Q10 (Ubiquinone):
Mitochondrial electron carrier with antioxidant function[14]:
Polyphenols:
Plant-derived antioxidants including resveratrol, curcumin, EGCG[15]:
Ferroptosis is an iron-dependent, non-apoptotic cell death pathway driven by lipid peroxidation[16]:
Key Features:
In Neurodegeneration:
GPx4 is the central regulator preventing ferroptosis[17]:
Inhibition Triggers Ferroptosis:
Lipid Peroxide Measurement:
Aldehyde Detection:
Isoprostanoids:
Immunohistochemistry:
Fluorescence Probes:
Vitamin E:
CoQ10:
N-acetylcysteine:
Nrf2 Activators:
Metal Chelation:
GPx4 Mimetics:
Ferroptosis Inhibitors:
APOE:
Other Variants:
Nrf2 Pathway:
Other Regulators:
Protective Factors:
Risk Factors:
Physical activity provides multiple benefits[18]:
Air Pollution:
Heavy Metals:
Mechanism Clarification:
Disease-Specific Issues:
Trial Design:
Combination Approaches:
Lipid peroxidation represents a fundamental pathological mechanism in neurodegenerative diseases, linking oxidative stress to membrane damage, protein dysfunction, and neuronal death. The cascade of PUFA oxidation generates diverse reactive species including lipid hydroperoxides and electrophilic aldehydes (4-HNE, MDA, acrolein), which propagate damage through covalent protein modifications and disruption of cellular membranes. The brain's high lipid content and oxygen consumption render it particularly vulnerable to peroxidative damage[19]. While enzymatic antioxidants (GPx, Prx, catalase) and dietary antioxidants (vitamin E, CoQ10, polyphenols) provide protective mechanisms, these become overwhelmed or decline with age and in neurodegenerative conditions. Understanding the detailed biochemistry of lipid peroxidation and its interactions with other disease mechanisms—including protein aggregation, mitochondrial dysfunction, and neuroinflammation—provides opportunities for developing targeted therapeutic interventions. Future research should focus on developing more selective antioxidants, identifying biomarkers for patient stratification, and implementing combination approaches that address multiple aspects of oxidative damage in neurodegenerative diseases.
The emergence of ferroptosis as an iron-dependent, lipid peroxidation-driven cell death pathway provides new therapeutic opportunities. The recognition that lipid peroxidation is not merely a secondary consequence but actively contributes to disease progression through multiple mechanisms suggests that targeting this pathway may yield disease-modifying benefits. Biomarkers of lipid peroxidation can serve both for disease diagnosis and monitoring treatment response, while lifestyle factors including diet and exercise can modulate oxidative stress burden and may provide preventive benefits[20].
'Lipid peroxidation in neurodegeneration: mechanisms and biomarkers'. Molecular Neurobiology. 2024. ↩︎
Brain lipid composition and vulnerability to oxidative damage. Neurobiology of Disease. 2024. ↩︎
Reactive aldehydes in neurodegeneration. Free Radic Biol Med. 2023. ↩︎
Chemistry and biochemistry of lipid peroxidation. Free Radic Biol Med. 1990. ↩︎
Membrane lipid peroxidation and neuronal dysfunction. Cellular and Molecular Neurobiology. 2022. ↩︎
Lipid peroxidation in Alzheimer's disease. Acta Neuropathol Commun. 2022. ↩︎
'4-HNE in Parkinson''s disease: neurotoxicity and therapeutic targets'. NPJ Parkinson's Disease. 2024. ↩︎
Oxidative stress and lipid peroxidation in ALS. Neurol Sci. 2020. ↩︎
Lipid peroxidation in Huntington's disease models. J Huntingtons Dis. 2023. ↩︎
Lipid peroxidation in multiple sclerosis lesions. Acta Neuropathol. 2022. ↩︎
Glutathione peroxidases in brain function. Biochim Biophys Acta. 2013. ↩︎
Peroxiredoxins in neuronal oxidative stress. Exp Biol Med (Maywood). 2005. ↩︎
Vitamin E and neurodegeneration. Annu Rev Nutr. 1999. ↩︎
CoQ10 and mitochondrial dysfunction. Ann Neurol. 2005. ↩︎
Polyphenols and oxidative stress in neurodegeneration. Pharmacol Res. 2022. ↩︎
'Ferroptosis: A regulated cell death nexus'. Cell. 2017. ↩︎
GPx4 and ferroptosis in neurodegeneration. Nat Cell Biol. 2014. ↩︎
Exercise and antioxidant defenses in brain. Ageing Res Rev. 2008. ↩︎
Targeting lipid peroxidation for neuroprotection. Pharmacol Ther. 2023. ↩︎
Ferroptosis inhibitors as neuroprotective agents. Front Cell Neurosci. 2022. ↩︎